Top Markets
Coin of the day
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Clasificación en acciones #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Precio por acción
$0.0005
Última sincronización: 2026-08-11
Capitalización bursátil
$16.73K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio ARYx Therapeutics, Inc. (ARYX)

Categoría

Historial del precio de la acción de ARYx Therapeutics, Inc. (ARYX)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $7.86 el 2007-11-01
Historial del precio de la acción de ARYx Therapeutics, Inc. desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 0.00%
2024 -35.90%
2023 56.00%
2022 -78.26%
2021 -47.20%
2020 133.23%
2019 15.59%
2018 -55.10%
2017 -15.05%
2016 97.24%
2015 -55.00%
2014 -53.19%
2013 71.35%
2012 -27.90%
2011 -97.10%
2010 -89.43%
2009 24.41%
2008 -72.51%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$166.06 27.73%
DE
$36.27 22.59%
JP
$228.90 41.12%
CH
$21.39 14.09%
IN